Johnson & Johnson Rolls Out Next-gen Intraocular Lens

SOUTH CAROLINA – October 1, 2024 – Johnson & Johnson announced that it expanded the rollout of its latest Tecnis Odyssey presbyopia-correcting intraocular lenses (PC-IOLs).

The new full visual range IOL offers a continuous, full range of vision, enabling sight from far, near and in between. It minimzes the need for glasses for those with presbyiopia, according to a news relesae.

J&J built the IOL on its existing Tecnis platform. The company said it provides two-times better contrast in low lighting compared to the Alcon PanOptix IOL. It also touts the ability for patients to read 14% smaller print on average compared to PanOptix users. Additionally, 93% of users reported zero or mild halos, glare or starbursts one month after surgery.

The company said it built Tecnis Odyssey with proprietary technology that results in superior image quality. It delivers sharp vision even in challenging lighting conditions, plus fewer visual disturbances. Johnson & Johnson says 94% of patients reported satisfaction with their overall vision without glasses.

Additionally, 96% of patients reported satisfaction with reading a smartphone or tablet and 97% were satisfied with distance vision. The company reports 92% satisfaction with the ability to see steps at night and read street signs at night.

“More than 14,000 eyes have already benefited from Tecnis Odyssey, our new full visual range IOL. Tecnis Odyssey patients have reported outstanding visual outcomes following surgery, which is why we are excited to announce we are expanding the roll-out across the U.S. today,” said Peter Menziuso, group chair, Vision, J&J. “Cataract surgery gives patients a once in a lifetime opportunity to improve their sight, and now with this advanced IOL, patients can see clearly at every distance, without the need for glasses.”

Join now to enjoy expanded member benefits!

Enjoy exclusive member content, special events, savings, networking and more

Paige Durham

SCbio is pleased to welcome Paige Durham to the team as communications coordinator to creatively and effectively communicate the value of the life science association’s programs and initiatives.

Durham will be responsible for developing and distributing high-quality content across multiple communications channels to build, advance and grow South Carolina’s life sciences industry, a key business sector for economic prosperity for the Palmetto State.

“SCbio is excited to welcome Paige to our team as our new communications coordinator. Paige brings fresh ideas and a strong background in communications that will be invaluable as we continue to strengthen our engagement with our audience,” said SCbio President and CEO James Chappell. “We are confident that her skills and experience will be crucial in advancing our communication strategies and supporting our mission.”

Before joining SCbio, Durham was the Membership and Communications Manager at the South Carolina Pharmacy Association (SCPhA), where she used her photography, design and writing skills to create content tailored to pharmacy professionals. Durham’s effective communication skills guaranteed the delivery of brand-specific material that captured the eye of her audience.

During her time at SCPhA, Durham created and edited the Palmetto Pharmacist Journal, using her creative vision to showcase members, educational institutions and industry news. Her communications efforts successfully gained new followers for the organization over the course of a year, increasing brand visibility and promoting the pharmacy profession.

Durham holds a Bachelor of Science in hospitality and tourism management and a Bachelor of Science in business administration from the College of Charleston.

Tamia Sumpter

Tamia is a driven senior undergraduate Bioengineering student currently enrolled at Clemson University. With a strong foundation in her field, she has honed her skills through hands-on experience in research and development at Eli Lilly & Company. During her time in the ADME department, Tamia contributed significantly by working on siRNAs and their applications in finding In Vitro-In Vivo Correlation (IVIVC). Looking ahead, Tamia has set her sights on a promising career in law. She aspires to specialize in Intellectual Property Law, with a particular focus on serving as in-house counsel for leading medical device or pharmaceutical companies. Her enthusiasm for this role is palpable as she prepares to embark on her legal journey! She is also a proud member of the Omicron Phi chapter of Delta Sigma Theta Sorority, Inc., PEER Mentor for Clemson PEER/WiSE, and currently serves as the President of Clemson Bioengineering Organization (CBO). With her unique blend of scientific knowledge and legal interests, Tamia is poised to make a meaningful impact in the healthcare and life sciences industries.